TBPH Stock Performance and Key Statistics

TBPH has a current P/E ratio of 23.81

The TBPH stock has a trailing twelve month price-to sales (P/S) ratio of 8.72 while its price-to-book (P/B) value is 3.

TBPH's price-to-free-cashflow (P/FCF) ratio is 2.88, an indicator that is currently being trending upward.

Based on TBPH's recent bid, its distance from 20 days simple moving average is -6.25%. It is -5.5% apart from 50 days simple moving average, and it is 23.07% apart from 200 days simple moving average.

The 52-week high for TBPH is $21.03 which is -13.5% away from the current price level whereas the distance of that from the 52-week low of $7.90 stands at 130.25%.

The performance of TBPH stock was not encouraging with most of its significant price indicators in green. Theravance Biopharma, Inc.(NASDAQ: TBPH) shares have moved downward -26.33% or - $4.99 in the latest trading session and have gained 9.14% year-to-date (YTD). The stock has gained nearly 141.94% over the past year. After moving 43.2% over the trailing 3-month period, the stock is 79.91% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 3.92% a week and 14.01% a month.

The current 14-day RSI for TBPH stock is 38.26. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Theravance Biopharma, Inc. (TBPH) has a 14-day ATR of 0.87.

After closing at $18.95 with 50.67M of its shares outstanding, the current enterprise value of TBPH is roughly 447.36M.

Theravance Biopharma, Inc. (NASDAQ: TBPH) is up 141.94% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 14.31%. TBPH stock price is also up 9.14% on its value in year-to-date trading.

The number outstanding shares of TBPH is 50.67M, and of these 91.92% shares are freely available for trading. On average, TBPH stock has traded 1.52M shares per day for the past 10 days. A total of 4.39M shares changed hands during the last trading session with the average session volume of 459.61K shares.